You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
While down 6 percent year-over-year, the estimate beats analysts estimates of $1.5 billion and reflects a stronger-than-expected rebound in test volumes.
The peer-reviewed study assessed sensitivity rates of HPV testing alone, Pap testing alone, and cotesting with both HPV and Pap tests.
Issued last week, the guidance said insurers were not required to reimburse such testing, which could impact coverage in schools, workplaces, and other settings.
With students and faculty scheduled to return in a few months, institutions are reaching out to secure testing to help keep the virus in check on campus.
The lab company is taking full ownership of MACL, the largest independent clinical lab in the state, which it formed as a joint venture around 20 years ago.
Launched by both national labs and regional and specialty firms, the offerings provide testing as well as guidance on how to best structure testing programs.
News items for the in vitro diagnostics industry for the week of June 1, 2020.
The FDA has added an at-home self-collection template to its SARS-CoV-2 EUA guidance as more firms seek to develop sampling kits for use in homes.
News items for the in vitro diagnostics industry for the week of May 25, 2020.
The company said that by the end of June it would have made available more than 500,000 kits, which allow individuals to self-collect nasal samples at home.